innovationNewsغير مصنف

Insulin drug maker Mannkind explores sale: sources

NEW YORK (Reuters) – Mannkind Corp , the U.S. maker of inhaled insulin drug Afrezza, is exploring strategic options, including the sale of itself, people familiar with the matter said on Tuesday.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى